Cheng Chen

15PUBLICATIONS
15CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsMedical infection agents (incl. prions)Humoural immunology and immunochemistryInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Sep 27, 2026
A Tumor-Boundary Niche Enriched for PD-1+CD8+T Cells and BTLA+B Cells Drives Resistance to Immunotherapy in NSCLC.

|Jun 25, 2026
Sequential involvement of hypoxia and anti-PD-1 treatment in shaping tumor-regional CD39+CD8+ T cells highlights immunotherapy-resistant features in NSCLC.

|Jun 24, 2026
Impact of early therapeutic modality on 28-day mortality in immunocompromised patients with opportunistic pulmonary infections: a multicenter retrospective study.

|Sep 09, 2025
Diagnostic and prognostic roles of interferon-λ1 and interferon-λ3 in bronchoalveolar lavage fluid and plasma in non-neutropenic patients with invasive pulmonary aspergillosis.

Chao Sun, Huanhuan Zhong, Yajie Lu

|May 22, 2025
Development and validation of a machine learning-based diagnostic model for identifying nonneutropenic invasive pulmonary aspergillosis in suspected patients: a multicenter cohort study.

Xinyu Wang, Yajie Lu, Chao Sun

|Jan 29, 2025
Pentraxin-3 as a novel prognostic biomarker in non-neutropenic invasive pulmonary aspergillosis patients.

Chao Sun, Xiaomin Cai, Huanhuan Zhong

Pageof 3

Frequent Collaborators

3 joint publications

Wenkui Sun

3 joint publications

Xin Su

2 joint publications

Qiuxia Qu

2 joint publications

Jiajuan Wu